DJT stock sinks double digits to reverse gains after Trump election win

Trump Media & Technology Group stock (DJT) sank double digits in premarket trading on Thursday, reversing the gains it enjoyed on Wednesday as Donald Trump clinched victory over Kamala Harris in the presidential election.

Shares in the company — the home of Trump’s social media platform, Truth Social — have been on a wild ride over the past week, with the up-and-down moves mostly tied to Trump’s chances of reclaiming the White House.

The stock is down about 10% over the past five days, although shares have rallied nearly 120% in the past month.

Strategists have categorized the stock as a binary bet on the election. Matthew Tuttle, CEO of investment fund Tuttle Capital Management, recently told Yahoo Finance’s Catalysts that the trajectory of shares has hinged on “a buy the rumor, sell the fact” trading strategy.

“I would imagine that the day after him winning, you’d see this come down,” he predicted at the time.

Interactive Brokers’ chief strategist Steve Sosnick said DJT has taken on a meme-stock “life of its own.”

“It was volatile on the way up, and when a stock is that volatile in one direction, it has a tendency to be that volatile in the other direction,” he said on a call with Yahoo Finance last week.

In September, shares in Trump Media traded at their lowest level since the company’s debut following the expiration of its highly publicized lockup period. The stock eventually bounced back from its lows as both domestic and overseas betting markets began to shift in favor of a Trump victory.

Trump founded Truth Social after he was kicked off major social media apps like Facebook (META) and Twitter, now X, following the Jan. 6, 2021, Capitol riots. Trump has since been reinstated on those platforms. He officially returned to posting on X in mid-August after about a year’s hiatus.

Republican presidential nominee former President Donald Trump arrives at an election night watch party at the Palm Beach Convention Center, Wednesday, Nov. 6, 2024, in West Palm Beach, Fla. (AP Photo/Evan Vucci)
Republican presidential nominee former President Donald Trump arrives at an election night watch party at the Palm Beach Convention Center, Wednesday, Nov. 6, 2024, in West Palm Beach, Fla. (AP Photo/Evan Vucci) · ASSOCIATED PRESS

As Truth Social attempts to take on social media incumbents, the fundamentals of the company have long been in question.

On Tuesday, DJT dropped third quarter results after the market close that revealed a net loss of $19.25 million for the quarter ending Sept. 30. This was narrower than the $26.03 million the company reported in the year-ago period.

DJT also reported revenue of $1.01 million, a slight year-over-year drop compared to the $1.07 million it reported in the third quarter of 2023. Over the past nine months ending Sept. 30, revenue has fallen 23% from the prior-year period.

Last month, the company revealed that its COO had stepped down in September.

Trump maintains a roughly 60% interest in DJT. At Wednesday’s closing price of around $36 a share, Trump Media boasted a market cap of about $7.2 billion, giving the former president a stake worth around $4.3 billion.

Stocks Extend Post-Election Gains Ahead of Fed: Markets Wrap

(Bloomberg) — US equity futures extended a post-Election Day advance as traders looked ahead to expectations that the Federal Reserve will cut interest rates later on Thursday.

Most Read from Bloomberg

S&P 500 contracts gained 0.2%, after the index notched a record high on Wednesday. The dollar retreated 0.6% following its best day since 2022. Treasury yields eased after Wednesday’s historic selloff. Jobless claims for the Nov. 2 week came in below estimates, highlighting the resilience of the labor market.

The Fed is expected to lower rates by a quarter-point and Chair Jerome Powell will hold a press conference later in the day that may provide details on the path for monetary policy. It’s also likely that Powell will face questions about what Donald Trump’s returns to the White House will mean for economic growth and inflation.

“What would be interesting is not so much the cut, but communication around December and next year,” James Vokins, portfolio manager at Aviva Investors, said in an interview. For Powell, “it will be a very difficult situation and it will be a very difficult communication to manage, he will have to be careful not to be too firm on any particular direction.”

Traders have pared back expectations for the Fed to lower interest rates over the next year on concern that Trump’s policies will exacerbate inflation. Money markets are currently betting on about 1 percentage point of Fed cuts by September 2025, compared to 1.1 percentage points on Tuesday.

While S&P 500 futures pointed toward more muted gains after Wednesday’s surge, Evercore ISI strategists said the rally was nowhere near done. Trump’s plans to slice through red tape could propel the S&P 500 another 11% through the middle of next year, they said.

History shows the bull market is “still an infant,” ISI strategist Julian Emanuel wrote in a note. “This market will be driven higher by the policy prospect of deregulation in DC,” he said, setting a price target for the index of 6,600 points by end-June 2025.

In the UK, the Bank of England lowered its key interest rate by 25 basis points to 4.75%. Governor Andrew Bailey said that borrowing costs are likely to fall “gradually from here” and that last week’s UK budget will lift inflation by just under half a percentage point at its peak.

Czech policymakers also delivered an eighth consecutive interest-rate cut as weak economic growth eclipsed concerns about inflationary risks.

Warner Bros. Discovery earnings: Stock rises amid streaming strength as studios, linear TV pressure revenue

Warner Bros. Discovery (WBD) stock rose about 5% in premarket trading on Thursday after the company reported strong streaming results in the third quarter that included its largest ever quarterly subscriber growth since the launch of Max. But revenue missed expectations as the media giant struggled with a drop in its studios segment and continued declines from its linear TV business.

Revenue came in at $9.62 billion, missing Bloomberg consensus expectations of $9.81 billion and a 3% drop compared to the $9.98 billion seen in Q3 2023.

The company reported adjusted earnings per share of $0.05 versus a loss of $0.17 in the year-earlier period. Consensus expectations had anticipated a loss closer to $0.09 a share.

In the second quarter, WBD took a massive $9.1 billion impairment charge related to its TV networks unit following the loss of its key NBA media rights. The company is currently tied up in litigation after suing the NBA in July, citing the “unjustified rejection” of its matching rights proposal.

Streaming served as bright spot in the quarter with 7.2 million subscribers added, a beat compared to estimates of a 6.1 million net increase and its largest quarterly subscriber growth yet. The additions were also ahead of the 700,000 subscriber loss the company reported in the year-earlier period.

The subscriber strength comes amid the recent launch of Max in markets outside of the US, including Latin America and Europe, along with increased bundling with competitors. Key programming, like the second season of “House of the Dragon,” along with the Olympics, also helped boost the metric.

Outside of strong subscribers, the company saw a 49% year-over-year jump in streaming advertising revenue.

Separately, the division posted profits of $289 million in the quarter compared to the $111 million it reported in Q3 2023. Recent price hikes have helped aid profits. The company boosted the price of its ad-free plans on Max in June.

On the earnings call, WBD management said revenue growth, profit growth, and subscriber growth are expected to continue in the current quarter with Q3 serving as a “material inflection point.”

The company also has its upcoming sports streaming partnership with Disney (DIS) and Fox (FOXA), although a judge temporarily blocked the launch, citing antitrust concerns.

Networks segment remains in free fall

Amid streaming’s success, other pockets of the business remained under pressure.

Advertising revenue for its networks unit plummeted 13% year over year after it dropped 10% in the second quarter and 11% in Q1. Analysts polled by Bloomberg had anticipated a more modest drop of 7%.

GoHealth Reports Third Quarter 2024 Results

CHICAGO, Nov. 07, 2024 (GLOBE NEWSWIRE) — GoHealth, Inc. GOCO (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and nine months ended September 30, 2024.

Third Quarter Highlights

  • Third quarter 2024 net revenues of $118.3 million, a $13.7 million decrease compared to $132.0 million in the prior year period.
  • Third quarter 2024 Submissions were 166,195, a 2.9% increase compared to 161,550 Submissions in the prior year period, with strong contributions from GoHealth’s internal captive agents, partially offset by a decline in Submissions from the external GoPartner Solutions (“GPS”) agents.
  • Third quarter 2024 net income of $15.4 million, an improvement of $71.6 million compared to a net loss of $56.2 million in the prior year period.
  • Third quarter 2024 Adjusted EBITDA(1) of negative $12.1 million, a decrease of $0.6 million compared to negative $11.5 million in the prior year period.
  • Third quarter 2024 trailing twelve months (“TTM”) positive cash flow from operations of $35.1 million, an increase of $38.3 million compared to TTM negative cash flow from operations of $3.2 million in the prior year period.
  • Refinanced Credit Facility, establishing new five-year term with new lender group.
  • Completed the strategic acquisition of e-TeleQuote Insurance, Inc. (“e-TeleQuote”), adding approximately $90.5 million in contract assets and $22.5 million in cash (inclusive of the Company’s initial $5.0 million investment), and recording a $77.4 million gain on bargain purchase, reinforcing GoHealth’s aspirations to expand its market leadership and operational capacity.
  • Achieved an 11.0% improvement in Direct Operating Cost per Submission(2) in the third quarter of 2024 compared to the prior year period, through advancements in artificial intelligence (“AI”), automation, and marketing efficiencies, along with targeted operational improvements.
  • Appointed Brendan Shanahan as Chief Financial Officer, who brings over 30 years of healthcare and financial strategy expertise to GoHealth.

“Our third-quarter results underscore the strength of our ongoing transformation into a Medicare engagement company. We’ve helped over 650,000 consumers navigate Medicare options through tools like PlanFit CheckUp, and with the addition of e-TeleQuote’s 400 agents, we’re prepared to efficiently serve the demand surge we are seeing in this year’s Medicare Annual Enrollment Period (“AEP”). We believe these developments reinforce GoHealth’s leadership in the eBroker space, positioning us for sustained growth and profitability,” said Vijay Kotte, CEO of GoHealth.

“The acquisition of e-TeleQuote not only added $90.5 million in contract assets and $22.5 million in cash (inclusive of our initial $5.0 million investment), but also provided a substantial gain on bargain purchase of $77.4 million, boosting our financial position,” Kotte continued. “This strategic move expanded our agent capacity ahead of a pivotal AEP, which we believe will enable us to capitalize on market demand. As the competitive landscape shifts, GoHealth aims to stand out, ready to support the millions of consumers facing benefit reductions or coverage losses.”

“GoHealth’s third-quarter results reflect disciplined cost management, as we reduced our Direct Operating Cost per Submission(2) by 11.0%, despite broader market challenges. These efficiency gains and a focus on high-quality lead generation underscore our commitment to driving profitable growth, especially as we progress through AEP,” said Brendan Shanahan, CFO of GoHealth. “With over $77 million gained through the e-TeleQuote acquisition, we believe we’re positioned with the liquidity and flexibility needed to drive long-term value, even as we expand our agent base during this critical AEP.”

“This AEP, we’re seeing unprecedented disruption, with over two million consumers losing coverage and more than six million experiencing reduced benefits. We believe GoHealth’s investments in AI-driven technology, an expanded agent network, and our focus on consumer engagement uniquely position us to lead through these market changes, delivering both growth and improved customer experience,” said Kotte.

(1) Adjusted EBITDA is a non-GAAP measure. For a definition of Adjusted EBITDA and a reconciliation to the most comparable GAAP measure, please see below.
(2) Direct Operating Cost per Submission is an operating metric. For a definition of Direct Operating Cost per Submission and an explanation of its calculation, please see below.
   

Conference Call Details

The Company will host a conference call today, Thursday, November 7, 2024 at 8:00 a.m. (ET) to discuss its financial results. A live audio webcast of the conference call will be available via GoHealth’s Investor Relations website, https://investors.gohealth.com/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call.

About GoHealth, Inc.

GoHealth is a leading health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers’ peace of mind when making healthcare decisions so they can focus on living life. For many of these consumers, enrolling in a health insurance plan is confusing and difficult, and seemingly small differences between health plans may lead to significant out-of-pocket costs or lack of access to critical providers and medicines. GoHealth’s proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer’s specific needs. Its unbiased, technology-driven marketplace coupled with highly skilled licensed agents has facilitated the enrollment of millions of consumers in Medicare plans since GoHealth’s inception. For more information, visit https://www.gohealth.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements are made in reliance upon the safe harbor provision of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release may be forward-looking statements. Statements regarding our future results of operations and financial position, business strategy and plans and objectives of management for future operations, including, among others, statements regarding our expected growth, future capital expenditures, debt service obligations, adoption and use of artificial intelligence technologies, the impact on our business from the acquisition of e-TeleQuote Insurance, Inc. (“e-TeleQuote”) and our ability to successfully integrate e-TeleQuote’s operations, technologies and employees into our business, are forward-looking statements.

In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “aims,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “likely,” “future” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this press release are only predictions, projections and other statements about future events that are based on current expectations and assumptions. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.

These forward-looking statements speak only as of the date of this press release and are subject to a number of important factors that could cause actual results to differ materially from those in the forward-looking statements, including the factors described in the sections titled “Summary Risk Factors,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (“2023 Annual Report on Form 10-K”) and in our other filings with the Securities and Exchange Commission. The factors described in our 2023 Annual Report on Form 10-K should not be construed as exhaustive and should be read together with the other cautionary statements included in this press release, as well as the cautionary statements and other risk factors set forth in the Quarterly Report on Form 10-Q for the first fiscal quarter ended March 31, 2024, the Quarterly Report on Form 10-Q for the second fiscal quarter ended June 30, 2024, the forthcoming Quarterly Report on Form 10-Q for the third quarter ended September 30, 2024 and in our other filings with the Securities and Exchange Commission.

You should read this press release and the documents that we reference in this press release completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Non-GAAP Financial Measures

Throughout this press release, we use a number of non-GAAP financial measures. Non-GAAP financial measures are supplemental measures of our performance that are derived from our consolidated financial information, but which are not presented in our Condensed Consolidated Financial Statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). We define these non-GAAP financial measures as follows:

  • “Adjusted EBITDA” represents, as applicable for the period, EBITDA as further adjusted for certain items summarized in the table furnished below in this press release.
     
  • “Adjusted EBITDA Margin” refers to Adjusted EBITDA divided by net revenues.
     
  • “EBITDA” represents net income (loss) before interest expense, income tax expense (benefit) and depreciation and amortization expense.

We believe that excluding certain items from our GAAP results allows management to better understand our consolidated financial performance from period to period and better project our future consolidated financial performance as forecasts are developed at a level of detail different from that used to prepare GAAP-based financial measures. Moreover, we believe these non-GAAP financial measures provide our stakeholders with useful information to help them evaluate our operating results by facilitating an enhanced understanding of our operating performance and enabling them to make more meaningful period to period comparisons. Adjusted EBITDA is the primary financial performance measure used by management to evaluate the business and monitor the results of operations, as well as a basis for certain compensation programs sponsored by the Company. There are limitations to the use of the non-GAAP financial measures presented in this press release. For example, our non-GAAP financial measures may not be comparable to similarly titled measures of other companies. Other companies, including companies in our industry, may calculate non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

The non-GAAP financial measures are not meant to be considered as indicators of performance in isolation from or as a substitute for the most directly comparable financial measures prepared in accordance with GAAP and should be read only in conjunction with financial information presented on a GAAP basis. Reconciliations of each of EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin to its most directly comparable GAAP financial measure are presented in the tables furnished below in this press release. We encourage you to review the reconciliations in conjunction with the presentation of the non-GAAP financial measures for each of the periods presented. In future periods, we may exclude similar items, may incur income and expenses similar to these excluded items and may include other expenses, costs and non-routine items.

Key Performance Indicators

In addition to traditional financial metrics, we rely upon certain business and operating metrics to evaluate our business performance and facilitate our operations. The most relevant business and operating metrics are as follows:

  • “Direct Operating Cost of Submission” is an operating metric that represents costs directly attributable to Submissions generated during a particular period and excludes costs that are indirect or fixed. Direct Operating Cost of Submission is comprised of the portion of the respective operating expenses for revenue share, marketing and advertising and consumer care and enrollment that are directly related to the Submissions generated in the particular period. Direct Operating Cost of Submission, most recently referred to as “Direct Cost of Submission,” reflects a name change only.
     
  • “Direct Operating Cost per Submission” is an operating metric that represents the average performance of Submissions generated during a particular period. Direct Operating Cost per Submission refers to (x) Direct Operating Cost of Submission for a particular period divided by (y) the number of Submissions generated for such period. Direct Operating Cost per Submission, most recently referred to as “Direct Cost per Submission” reflects a name change only.
     
  • “Sales/Direct Operating Cost of Submission” represents (x) the numerator of Sales per Submission, as defined below, divided by (y) Direct Operating Cost of Submission. Sales/Direct Operating Cost of Submission, most recently referred to as “Sales/Direct Cost of Submission” reflects a name change only.
     
  • “Sales per Submission” is an operating metric that represents the average performance of Submissions generated during a particular period. Sales per Submission measures revenues only from the Submissions generated in the period and excludes items that are unrelated to such Submissions, including any impact of revenue adjustments recorded in the period, but relating to performance obligations satisfied in prior periods. Sales per Submission equals (x) the sum of (i) agency revenues, comprised of the expected amount of initial commission revenue and any renewal commissions to be paid from the health plan partners on such placement as long as the policyholder remains with the same insurance product, as well as partner marketing and other revenue and (ii) non-agency revenues, comprised of the enrollment and engagement services for which cash is collected in advance or in close proximity to the point in time revenue is recognized, divided by (y) the number of Submissions generated for such period.
     
  • “Submission” refers to either (i) a completed application with our licensed agent that is submitted to the health plan partner and subsequently approved by the health plan partner during the indicated period, excluding applications through our Non-Encompass BPO Services or (ii) a transfer by our agent to the health plan partner through the Encompass operating model during the indicated period.

Direct Operating Cost of Submission, Direct Operating Cost per Submission, Sales/Direct Operating Cost of Submission, Sales per Submission and Submissions are key operating metrics we use to understand our underlying financial performance and trends.

Certain Definitions and Key Terms

As used in this press release, unless the context otherwise requires:

  • “LTV” refers to the Lifetime Value of Commissions, which we define as aggregate commissions estimated to be collected over the estimated life of all commissionable Submissions for the relevant period based on multiple factors, including but not limited to, contracted commission rates, health plan partner mix and expected policy persistency with applied constraints.
     
  • “Non-Encompass BPO Services” refer to programs in which GoHealth-employed agents are dedicated to certain health plans and agencies we partner with outside of the Encompass operating model.

The following tables set forth the components of our results of operations for the periods indicated (unaudited):

      Three months ended Sep. 30,        
        2024       2023          
(in thousands, except percentages and per share amounts)     Dollars   % of Net Revenues   Dollars   % of Net Revenues   $ Change   % Change
Net revenues     $ 118,292     100.0 %   $ 132,037     100.0 %   $ (13,745 )   (10.4) %
Operating expenses:                          
Revenue share       19,683     16.6 %     35,992     27.3 %     (16,309 )   (45.3) %
Marketing and advertising       45,270     38.3 %     39,416     29.9 %     5,854     14.9 %
Consumer care and enrollment       45,556     38.5 %     46,472     35.2 %     (916 )   (2.0) %
Technology       9,801     8.3 %     11,652     8.8 %     (1,851 )   (15.9) %
General and administrative       17,140     14.5 %     12,967     9.8 %     4,173     32.2 %
Amortization of intangible assets       23,514     19.9 %     23,514     17.8 %         %
Total operating expenses       160,964     136.1 %     170,013     128.8 %     (9,049 )   (5.3) %
Income (loss) from operations       (42,672 )   (36.1) %     (37,976 )   (28.8) %     (4,696 )   12.4 %
Interest expense       19,086     16.1 %     17,565     13.3 %     1,521     8.7 %
Gain on bargain purchase       (77,363 )   (65.4) %         %     (77,363 )   NM
Other (income) expense, net       250     0.2 %     771     0.6 %     (521 )   (67.6) %
Income (loss) before income taxes       15,355     13.0 %     (56,312 )   (42.6) %     71,667     (127.3) %
Income tax (benefit) expense       (11 )   %     (108 )   (0.1) %     97     (89.8) %
Net income (loss)     $ 15,366     13.0 %   $ (56,204 )   (42.6) %   $ 71,570     (127.3) %
Net income (loss) attributable to non-controlling interests       8,591     7.3 %     (32,294 )   (24.5) %     40,885     (126.6) %
Net income (loss) attributable to GoHealth, Inc.     $ 6,775     5.7 %   $ (23,910 )   (18.1) %   $ 30,685     (128.3) %
Net Income (Loss) Margin       13.0 %       (42.6) %            
Net income (loss) per share:                          
Net income (loss) per share of Class A common stock — basic     $ 0.58         $ (2.61 )            
Net income (loss) per share of Class A common stock — diluted     $ 0.46         $ (2.61 )            
Weighted-average shares of Class A common stock outstanding — basic       10,077           9,489              
Weighted-average shares of Class A common stock outstanding — diluted       14,580           9,489              
                           
Non-GAAP financial measures:                          
EBITDA     $ 60,860         $ (12,482 )            
Adjusted EBITDA     $ (12,106 )       $ (11,475 )            
Adjusted EBITDA Margin     (10.2) %       (8.7) %            
                           

NM = Not meaningful

      Nine months ended Sep. 30,        
        2024       2023          
(in thousands, except percentages and per share amounts)     Dollars   % of Net Revenues   Dollars   % of Net Revenues   $ Change   % Change
Net revenues     $ 409,762     100.0 %   $ 457,974     100.0 %   $ (48,212 )   (10.5) %
Operating expenses:                          
Revenue share       78,376     19.1 %     117,876     25.7 %     (39,500 )   (33.5) %
Marketing and advertising       136,049     33.2 %     124,428     27.2 %     11,621     9.3 %
Consumer care and enrollment       132,731     32.4 %     134,035     29.3 %     (1,304 )   (1.0) %
Technology       28,921     7.1 %     31,706     6.9 %     (2,785 )   (8.8) %
General and administrative       50,457     12.3 %     73,440     16.0 %     (22,983 )   (31.3) %
Amortization of intangible assets       70,542     17.2 %     70,543     15.4 %     (1 )   %
Operating lease impairment charges           %     2,687     0.6 %     (2,687 )   (100.0) %
Total operating expenses       497,076     121.3 %     554,715     121.1 %     (57,639 )   (10.4) %
Income (loss) from operations       (87,314 )   (21.3) %     (96,741 )   (21.1) %     9,427     (9.7) %
Interest expense       55,133     13.5 %     51,721     11.3 %     3,412     6.6 %
Gain on bargain purchase       (77,363 )   (18.9) %         %     (77,363 )   NM
Other (income) expense, net       332     0.1 %     739     0.2 %     (407 )   (55.1) %
Income (loss) before income taxes       (65,416 )   (16.0) %     (149,201 )   (32.6) %     83,785     (56.2) %
Income tax (benefit) expense       (122 )   %     (225 )   %     103     (45.8) %
Net income (loss)     $ (65,294 )   (15.9) %   $ (148,976 )   (32.5) %   $ 83,682     (56.2) %
Net income (loss) attributable to non-controlling interests       (36,857 )   (9.0) %     (86,945 )   (19.0) %     50,088     (57.6) %
Net income (loss) attributable to GoHealth, Inc.     $ (28,437 )   (6.9) %   $ (62,031 )   (13.5) %   $     33,594     (54.2) %
Net Income (Loss) Margin     (15.9) %       (32.5) %            
Net income (loss) per share:                          
Net income (loss) per share of Class A common stock — basic     $ (3.14 )       $ (7.04 )            
Net income (loss) per share of Class A common stock — diluted     $ (3.14 )       $ (7.04 )            
Weighted-average shares of Class A common stock outstanding — basic       9,922           9,194              
Weighted-average shares of Class A common stock outstanding — diluted       9,922           9,194              
                           
Non-GAAP financial measures:                          
EBITDA     $ 68,679         $ (18,580 )            
Adjusted EBITDA     $ 2,479         $ 18,091              
Adjusted EBITDA Margin       0.6 %         4.0 %            
                           

NM = Not meaningful

The following tables set forth the reconciliations of GAAP net income (loss) to EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin for the periods indicated (unaudited):

      Three months ended Sep. 30,   Nine months ended Sep. 30,
(in thousands)       2024       2023       2024       2023  
Net revenues     $ 118,292     $ 132,037     $ 409,762     $ 457,974  
Net income (loss)       15,366       (56,204 )     (65,294 )     (148,976 )
Interest expense       19,086       17,565       55,133       51,721  
Income tax expense (benefit)       (11 )     (108 )     (122 )     (225 )
Depreciation and amortization expense       26,419       26,265       78,962       78,900  
EBITDA       60,860       (12,482 )     68,679       (18,580 )
Gain on bargain purchase(1)       (77,363 )           (77,363 )      
Share-based compensation expense (benefit)(2)       2,859       (545 )     6,534       16,159  
Professional services(3)       818       1,213       818       1,213  
Legal fees(4)       654       339       1,331       14,692  
Severance costs(5)       66             2,480       1,920  
Operating lease impairment charges(6)                         2,687  
Adjusted EBITDA     $ (12,106 )   $ (11,475 )   $ 2,479     $ 18,091  
Net Income (Loss) Margin       13.0 %   (42.6) %   (15.9) %   (32.5) %
Adjusted EBITDA Margin     (10.2) %   (8.7) %     0.6 %     4.0 %
(1) Represents the excess of the acquisition-date fair value of the net assets acquired over the acquisition-date fair value of the consideration transferred related to the acquisition of e-TeleQuote.
(2) Represents non-cash share-based compensation expense (benefit) relating to equity awards as well as share-based compensation expense (benefit) relating to liability classified awards that will be settled in cash.
(3) Represents costs primarily associated with non-recurring consulting fees and other professional services.
(4) Represents legal fees, settlement accruals and other expenses related to certain acquisitions, litigation, Credit Agreement amendments and other non-routine legal or regulatory matters.
(5) Represents severance costs and other fees associated with a reduction in workforce unrelated to restructuring activities.
(6) Represents operating lease impairment charges, reducing the carrying value of the associated right-of-use (“ROU”) assets and leasehold improvements to the estimated fair values.
   

The table below depicts the disaggregation of revenue and is consistent with how the Company evaluates its financial performance (unaudited):

      Three months ended Sep. 30,   Nine months ended Sep. 30,
(in thousands)       2024     2023     2024     2023
Medicare Revenue                  
Agency Revenue                  
Commission Revenue(1)     $                77,868   $                76,579   $               228,154   $               261,513
Partner Marketing and Other Revenue                        14,408                      21,300                      47,926                      71,619
Total Agency Revenue                        92,276                      97,879                     276,080                     333,132
Non-Agency Revenue                        24,377                      33,510                     130,723                     106,586
Total Medicare Revenue                       116,653                     131,389                     406,803                     439,718
Other Revenue                  
Non-Encompass BPO Services Revenue                                —                              —                              —                        9,322
Other Revenue                          1,639                           648                        2,959                        8,934
Total Other Revenue                          1,639                           648                        2,959                      18,256
Total Net Revenues     $               118,292   $               132,037   $               409,762   $               457,974
(1) Commission revenue excludes commissions generated through the Company’s Non-Encompass BPO Services as well as from the sale of individual and family plan insurance products.
   

The following table summarizes share-based compensation expense (benefit) by operating function for the periods indicated (unaudited):

      Three months ended Sep. 30,   Nine months ended Sep. 30,
(in thousands)       2024     2023       2024     2023
Marketing and advertising     $                       75   $                     149     $                     203   $                     378
Customer care and enrollment                             189                           519                             841                        1,847
Technology                             293                           676                             780                        2,365
General and administrative(1)                          2,302                       (1,889 )                        4,710                      11,569
Total share-based compensation expense (benefit)     $                  2,859   $                    (545 )   $                  6,534   $                16,159
(1) For the three and nine months ended September 30, 2024 and 2023, share-based compensation expense (benefit) includes expense (benefit) related to the stock appreciation rights (“SARs”), which are liability classified awards.
   

The following table sets forth our balance sheets for the periods indicated (unaudited):

(in thousands, except per share amounts)     Sep. 30, 2024   Dec. 31, 2023
Assets          
Current assets:          
Cash and cash equivalents     $            35,527     $            90,809  
Accounts receivable, net of allowance for doubtful accounts of $2 in 2024 and $27 in 2023                      6,862                         250  
Commissions receivable – current                  270,383                  336,215  
Prepaid expense and other current assets                    21,271                    49,166  
Total current assets                  334,043                  476,440  
Commissions receivable – non-current                  627,341                  575,482  
Operating lease ROU asset                    20,449                    21,995  
Property, equipment, and capitalized software, net                    30,418                    26,843  
Intangible assets, net                  326,011                  396,554  
Other long-term assets                      2,891                      2,256  
Total assets     $       1,341,153     $       1,499,570  
Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity          
Current liabilities:          
Accounts payable     $            15,285     $            17,705  
Accrued liabilities                    49,475                    86,254  
Commissions payable – current                    80,899                  118,732  
Short-term operating lease liability                      5,541                      5,797  
Deferred revenue                    42,696                    52,403  
Current portion of long-term debt                    65,000                    75,000  
Other current liabilities                    23,075                    14,122  
Total current liabilities                   281,971                  370,013  
Non-current liabilities:          
Commissions payable – non-current                  177,023                  203,255  
Long-term operating lease liability                    36,187                    39,547  
Deferred tax liabilities                    24,995                           —  
Long-term debt, net of current portion                   416,332                  422,705  
Other non-current liabilities                      7,363                      9,095  
Total non-current liabilities                   661,900                  674,602  
Commitments and Contingencies          
Series A redeemable convertible preferred stock — $0.0001 par value; 50 shares authorized; 50 shares issued and outstanding as of both September 30, 2024 and December 31, 2023. Liquidation preference of $53.7 million and $50.9 million as of September 30, 2024 and December 31, 2023, respectively.                    52,023                    49,302  
Stockholders’ equity:          
Class A common stock – $0.0001 par value; 1,100,000 shares authorized; 10,440 and 9,823 shares issued; 10,121 and 9,651 shares outstanding as of September 30, 2024 and December 31, 2023, respectively.                             1                             1  
Class B common stock – $0.0001 par value; 615,980 and 616,018 shares authorized; 12,775 and 12,814 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.                             1                             1  
Preferred stock – $0.0001 par value; 20,000 shares authorized (including 50 shares of Series A redeemable convertible preferred stock authorized and 200 shares of Series A-1 convertible preferred stock authorized); 50 shares issued and outstanding as of both September 30, 2024 and December 31, 2023.                           —                           —  
Series A-1 convertible preferred stock— $0.0001 par value; 200 shares authorized; no shares issued and outstanding as of both September 30, 2024 and December 31, 2023.                           —                           —  
Treasury stock – at cost; 319 and 173 shares of Class A common stock as of September 30, 2024 and December 31, 2023, respectively.                     (4,124 )                   (2,640 )
Additional paid-in capital                  665,020                  654,059  
Accumulated other comprehensive income (loss)                       (141 )                     (127 )
Accumulated deficit                 (448,717 )               (420,280 )
Total stockholders’ equity attributable to GoHealth, Inc.                  212,040                  231,014  
Non-controlling interests                  133,219                  174,639  
Total stockholders’ equity                  345,259                  405,653  
Total liabilities, redeemable convertible preferred stock and stockholders’ equity     $       1,341,153     $       1,499,570  
                   

The following table sets forth the net cash provided by (used in) operating activities for the periods presented (unaudited):

Net cash provided by (used in) operating activities   Nine months ended Sep. 30,   Trailing Twelve Months ended Sep. 30,
    2024       2023     2024     2023  
    $ (36,211 )   $ 37,840   $ 35,091   $ (3,159 )
                             

In addition to traditional financial metrics, we rely upon certain business and operating metrics to evaluate our business performance and facilitate our operations. Below are the most relevant business and operating metrics for our single operating and reportable segment.

The following table presents the number of Submissions for the periods presented:

Submissions   Three months ended Sep. 30,        
  2024   2023   Change   % Change
                  166,195                   161,550                      4,645     2.9%
               
  Nine months ended Sep. 30,        
  2024   2023   Change   % Change
                  534,737                   538,032                     (3,295 )   (0.6)%
                   

The following table presents the Sales per Submission for the periods presented:

Sales Per Submission   Three months ended Sep. 30,        
    2024     2023   $ Change   % Change
  $                     702   $                     813   $                    (111 )   (13.7)%
               
  Nine months ended Sep. 30,        
    2024     2023   $ Change   % Change
  $                     761   $                     817   $                      (56 )   (6.9)%
                         

The following table presents the Direct Operating Cost per Submission for the periods presented:

Direct Operating Cost Per Submission   Three months ended Sep. 30,        
    2024     2023   $ Change   % Change
  $                     663   $                     745   $                      (82 )   (11.0)%
               
  Nine months ended Sep. 30,        
    2024     2023   $ Change   % Change
  $                     647   $                     679   $                      (32 )   (4.7)%
                         

The following are our Direct Operating Cost of Submission (in thousands) and Sales/Direct Operating Cost of Submission for the periods presented:

      Three months ended Sep. 30,   Nine months ended Sep. 30,
        2024     2023     2024     2023
Direct Operating Cost of Submission     $               110,245   $               120,362   $               346,112   $               365,612
Sales/Direct Operating Cost of Submission                              1.1                            1.1                            1.2                            1.2


Primary Logo

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket

Shares of Lyft, Inc. LYFT rose sharply in today’s pre-market trading after the company reported better-than-expected quarterly results.

Lyft reported quarterly losses of three cents per share which beat the analyst consensus estimate for losses of four cents. Quarterly revenue came in at $1.52 billion which beat the analyst consensus estimate of $1.44 billion and is an increase over sales of $1.15 billion from the same period last year.

Lyft shares rose 21.5% to $17.49 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • AtlasClear Holdings, Inc. ATCH gained 89.6% to $0.3412 in pre-market trading after gaining around 13% on Wednesday.
  • Interactive Strength Inc. TRNR rose 81.5% to $0.1650 in pre-market trading. Interactive Strength will release third quarter results before the market opens on Thursday, Nov. 14.
  • MDJM Ltd MDJH shares surged 49.7% to $0.2252 in pre-market trading after declining around 6% on Wednesday.
  • Ensysce Biosciences, Inc. ENSC gained 32.6% to $0.7305 in pre-market trading after gaining 5% on Wednesday.
  • AppLovin Corporation APP climbed 27.5% to $214.84 in pre-market trading after the company reported better-than-expected third-quarter financial results.
  • Laird Superfood, Inc.  LSF shares rose 22% to $8.99 in pre-market trading after the company reported better-than-expected third-quarter financial results.
  • Emergent BioSolutions Inc. EBS gained 19.8% to $11.03 in pre-market trading after posting strong quarterly earnings.
  • Freshworks Inc. FRSH gained 17.7% to $15.40 in pre-market trading following better-than-expected quarterly earnings.
  • The Oncology Institute, Inc TOI gained 17.6% to $0.3469 in pre-market trading. The Oncology Institute will release its third quarter financial results after the market close on Wednesday, Nov. 13.
  • Dutch Bros Inc. BROS gained 15.8% to $40.49 in pre-market trading following strong quarterly results.

Losers

  • Digital Turbine, Inc. APPS shares tumbled 41.1% to $1.91 in pre-market trading after reporting downbeat quarterly results.
  • FOXO Technologies Inc. FOXO shares fell 32% to $0.5321 in pre-market trading after surging 475% on Wednesday.
  • Cardlytics, Inc. CDLX dipped 31.9% to $3.55 in pre-market trading following third-quarter results.
  • Wolfspeed, Inc. WOLF shares fell 24.5% to $10.35 in pre-market trading after the company reported third-quarter financial results.
  • SolarEdge Technologies, Inc. SEDG declined 19% to $11.89 in pre-market trading following third-quarter results.
  • Burford Capital Limited BUR shares dipped 16.4% to $12.21 in pre-market trading. Burford Capital will release its financial results for the three and nine months ended Sept. 30, on Thursday, Nov. 7.
  • ARB IOT Group Limited ARBB fell 15.4% to $0.6879 in pre-market trading after surging 44% on Wednesday.
  • Corsair Gaming Inc CRSR fell 14.1% to $6.12 in today’s pre-market trading after the company reported worse-than-expected financial results.
  • Match Group, Inc. MTCH fell 12.8% to $33.00 in pre-market trading following mixed third-quarter financial results.
  • Sutro Biopharma, Inc. STRO fell 11.6% to $3.66 in pre-market trading after gaining around 8% on Wednesday.

Now Read This:

Market News and Data brought to you by Benzinga APIs

Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders

Leads Biolabs grants Oblenio Bio an exclusive option to license LBL-051, a first-in-class CD19xBCMAxCD3 tri-specific T-cell engager antibody

OAKLAND, Calif. and NANJING, China, Nov. 7, 2024 /PRNewswire/ — Aditum Bio and Leads Biolabs today announced the formation of Oblenio Bio, which is being formed in conjunction with an exclusive option and license agreement to develop LBL-051, a first-in-class CD19xBCMAxCD3 tri-specific T-cell engager antibody for autoimmune diseases. Aditum Bio will fund Oblenio Bio and the parties will collaborate to rapidly bring LBL-051 into clinical studies.

Recent clinical data from CD19 and BCMA targeted therapies have demonstrated compelling efficacy in difficult-to-treat autoimmune diseases. Despite these promising results, there is a continued unmet need for increased efficacy and durability. By targeting both CD19 and BCMA, LBL-051 has the potential to deliver stronger and more durable responses by depleting a broader range of pathological B-cell populations across a wide spectrum of antibody-mediated autoimmune diseases.

LBL-051 is a novel tri-specific T-cell engager developed using the LeadsBody Platform. Each target binding domain CD19, BCMA, and CD3- has been engineered with the intent of enhancing safety while optimizing efficacy by finely tuning the relative potency of each domain.

Under the terms of the agreement, Leads Biolabs will grant Oblenio an exclusive option to develop, manufacture, and commercialize LBL-051 worldwide. Leads Biolabs is eligible to receive up to $35 million in upfront and near-term payments, $579 million in development, regulatory, and commercialization milestone payments, as well as royalties on sales. Additionally, Leads Biolabs is entitled to receive an equity stake in Oblenio Bio.

“By targeting both CD19 and BCMA in autoimmune disorders, LBL-051 has the potential to achieve a complete immune reset and superior efficacy and durability, compared to single targeting of either CD19 or BCMA alone”, said Joe Jimenez, Co-Founder and Managing Director of Aditum Bio. Dr. Xiaoqiang Kang, Founder, Chairman and CEO of Leads Biolabs added, “LBL-051 offers a differentiated approach to treating certain autoimmune conditions and has the potential to be a Pipeline in a Product. We are pleased to establish this partnership with the high caliber team at Aditum to bring this innovative therapy to patients around the world”.

Oblenio Bio is the thirteenth company launched by Aditum Bio, whose mission is to give large patient populations access to important medicines. To speed these drugs to market, Aditum Bio fosters an incubator model, focusing on the translational phase of drug development. The “spin out” model enables a nimble, start-up platform with a dedicated team of managers supported by Aditum’s in-house team of development professionals.

About Aditum Bio

Aditum Bio is a biotech venture firm committed to improving health by accelerating drug development in disease areas with high unmet need where medical innovation can have a significant impact. Aditum Bio in-licenses promising drug candidates and spins out individual companies dedicated to bringing each candidate through early clinical trials. For more information, please visit www.aditumbio.com.

About Leads Biolabs

Founded in 2014, Nanjing Leads Biolabs Co., Ltd. is a clinical-stage biotechnology company based in Nanjing, China, with operations extending to the U.S. Our focus is to discover and develop innovative therapies that address significant unmet medical needs in oncology, autoimmune diseases, metabolic disorders, and other serious conditions. Our robust R&D pipeline includes over twenty novel candidates across various modalities, including monoclonal antibodies, multi-specific antibodies, T cell engagers, and antibody-drug conjugates (ADCs). For more information, please visit www.leadsbiolabs.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/aditum-bio-and-leads-biolabs-announce-the-formation-of-oblenio-bio-to-develop-a-tri-specific-t-cell-engager-for-autoimmune-disorders-302297928.html

SOURCE Aditum Bio

Market News and Data brought to you by Benzinga APIs

REVEL Welcomes Powerhouse Broker Trio To Lead REVEL DURHAM expansion office

NIAGARA FALLS, ON, Nov. 6, 2024 /CNW/ – Revel Realty, an independent real estate brokerage with headquarters based in Niagara Falls, Ontario, is excited to announce that the powerhouse broker trio of Doug Gordon, Walid Dorani and Gino Spagnuolo will lead REVEL’s expansion into Durham. Building upon recent expansion in Toronto West, REVEL Durham will begin to triangulate the Greater Toronto Area with the REVEL brand, while establishing a prominent presence in areas north and east of the metropolis. Having already staked a claim on this marketplace with a homegrown reputation of hard work and ethical business practices, Doug, Walid and Gino will form a unique leadership team with the intent of growing REVEL’s market share in a thriving, and developing region of Ontario.

“I joined Revel because they stand apart from the status quo, driven by great leadership with a progressive vision that aligns with my goals,” explains Doug Gordon. “I want to be a part of and help grow an inspiring brand. Under the Revel brand, I hope to help foster a dynamic, professional environment where true collaboration and innovation thrives in order to provide exceptional value for our real estate clients.”

“The breaking away from conventional practices resonates with my own approach to real estate,” adds Gino Spagnuolo. “With forward-thinking leadership and a brand vision that focuses on elevating the industry, I’m excited to contribute to this culture of innovation, growth, and success.”

“I remember starting out in the real estate business and feeling like a fish out of water,” adds Walid Dorani. “Everyone seemed to be doing their own thing, and there wasn’t much collaboration or mentorship. That’s why REVEL’s innovative and dynamic approach stood out to me. What I love about REVEL is the supportive community of like-minded professionals who are driven and incentivized to help each other succeed. Having a head coach in place means agents get real, hands-on support to help them thrive. My goal under the REVEL brand is to foster that growth and mentorship, creating an environment where agents feel empowered and fully equipped to take their business to new heights.”

Such an expansion move marks a major milestone for REVEL’S 10th anniversary in business.  With a goal in 2024 to grow by ten offices to commemorate ten years in business, REVEL Durham will be the official tenth office, realizing the fulfillment of this prognostication, and validation for a brand that continues its exponential growth.  In 2024 alone Revel expanded to Timmins, Waterloo, Campbellville, Espanola, St. Catharines and Niagara-on-the-Lake(McGarr Realty Alliance), Kingston, Toronto West, and most recently, North Bay.  To include three, reputable and renowned brokers to REVEL’s stable of leaders will do well to extend and bolster REVEL’s far reaching network, as well as add to the growing list of expansion offices, which will most likely exceed expectations with a few more slated to be announced before the end of the calendar year. 

REVEL regards this trio of talent as a major expansion advantage for a brand that truly values the people who have earned promotional opportunities through impressive work ethics and an adoption of the business principles REVEL insists upon for each of its 33 offices in Ontario.

“We are honoured to welcome Doug, Walid, Gino and their team into our REVEL family. Our ambitions and visions for real estate are like minded, as well as our passions to offer elite service to our clients and colleagues,” explains founder of REVEL, Ryan Serravalle. “To acquire three incredible leaders, who will drive REVEL Durham, is a first for us, and one that we are extremely excited about.”

REVEL is confident that its focus on education, coaching, training, mentorship, and creative marketing, not to mention its top ten branding influence in the province of Ontario, will continue to create opportunities for agents, affiliations, and client networks throughout the province and beyond.

“We are overwhelmed with enthusiasm when we attract agents, brokers and teams that share our core principles of business,” adds Nicki Serravalle, founder of REVEL. “At REVEL, we work to create confidence in our agents so that they aspire to leadership positions. Doug, Walid and Gino already have a headstart in this regard.”

From its inaugural launch in 2014, founders of REVEL, Ryan and Nicki Serravalle, have built an alluring brand, which has inspired a demographic of real estate professionals to conduct business in a REVELutionary manner. Attracting some of the highest selling teams in the nation, while developing a contingent of industry leading agents through its innovative REVEL Ed and REVEL Mentorship programs, REVEL has established itself as a credible and promising option for reputable real estate agents, brokers, and prominent teams, who are seeking to take the next step in their career paths – leadership, ownership of, or partnership with, a REVEL office.

SOURCE Revel Realty Inc Brokerage

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2024/06/c7089.html

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

source

Sportradar Reports Third Quarter 2024 Financial Results and Further Raises Full Year 2024 Outlook

Third Quarter 2024 Highlights

  • Revenue increased 27% to €255 million
  • Profit for the period increased €33 million to €37 million and expanded to 14.5% as a percentage of revenue
  • Adjusted EBITDA1 increased 30% to €66 million and Adjusted EBITDA margin1 expanded to 25.8%
  • Net cash generated from operating activities increased 55% to €118 million and Free cash flow1 increased 192% to €62 million
  • Customer Net Retention Rate1 increased to 126%
  • Repurchased $8.3 million of shares
  • Further raised full year guidance to revenue growth of at least 24% to €1,090 million and Adjusted EBITDA growth of at least 29% to €216 million

ST. GALLEN, Switzerland, Nov. 07, 2024 (GLOBE NEWSWIRE) — Sportradar Group AG SRAD (“Sportradar” or the “Company”), a leading global sports technology company focused on creating immersive experiences for sports fans and bettors, today announced financial results for its third quarter ended September 30, 2024.

Carsten Koerl, Chief Executive Officer of Sportradar, said: “Our competitive advantages within the sports ecosystem, coupled with our growth-oriented strategy, is driving broad-based outperformance. We continue to deliver more value to our clients and partners, building shareholder value. We are at an important inflection point to drive operational leverage and cash generation, demonstrated by our expanding EBITDA margin and strong cash flow this past quarter. The significant cash flow has further strengthened our balance sheet and we are deploying our capital to execute on our growth strategy while returning capital to shareholders. Additionally, we continue to show strong momentum in the US, which we expect to be further bolstered by the growth of in-game betting and with the start of the NBA and NHL seasons.”

THIRD QUARTER AND YEAR TO DATE FINANCIAL RESULTS

Revenue

    Three-Month Period Ended
September 30,
  Nine-Month Period Ended
September 30,
in € thousands (unaudited)   2024   2023   Change   %   2024   2023   Change   %
Revenue by product                                
Betting & Gaming Content   162,769   118,994   43,775   37 %   515,337   382,352   132,985   35 %
Managed Betting Services   47,295   40,190   7,105   18 %   144,726   117,521   27,205   23 %
Betting Technology & Solutions   210,064   159,184   50,880   32 %   660,063   499,873   160,190   32 %
                                 
Marketing & Media Services   32,944   30,080   2,864   10 %   102,637   90,185   12,452   14 %
Sports Performance   10,116   9,949   167   2 %   29,314   29,150   164   1 %
Integrity Services   2,048   1,824   224   12 %   7,472   5,827   1,645   28 %
Sports Content, Technology & Services   45,108   41,853   3,255   8 %   139,423   125,162   14,261   11 %
Total Revenue   255,172   201,037   54,135   27 %   799,486   625,035   174,451   28 %
                                 
Revenue by geography                                
Rest of World   204,076   165,960   38,116   23 %   622,340   512,263   110,077   21 %
United States   51,096   35,077   16,019   46 %   177,146   112,772   64,374   57 %
Total Revenue   255,172   201,037           799,486   625,035        
 

Total revenue for the third quarter was €255 million, up €54 million, or 27% year-over-year driven by 32% growth in Betting Technology & Solutions and 8% growth in Sports Content, Technology & Services.

Betting Technology & Solutions revenues of €210 million were up 32% year-over-year primarily driven by a 37% increase in Betting & Gaming Content benefiting from existing and new customer uptake of our products and premium pricing, as well as from the strong U.S. market growth. Additionally, Managed Betting Services grew 18% year-over-year, primarily driven by strong growth in Managed Trading Services from higher trading margins and increased betting activity from existing and new customers.

Sports Content, Technology & Services revenues of €45 million, increased 8% year-over-year primarily driven by 10% growth in Marketing & Media Services with strong growth in both European and North America ad:s revenue as several sportsbooks launched marketing campaigns.

The Company generated strong revenue growth globally with Rest of World up 23% and the United States up 46%. As a percentage of total Company revenues, United States revenue represented 20% of total Company revenue in the third quarter as compared to 17% in the prior year quarter due to market growth, additional customer uptake of our products and premium pricing.

Customer Net Retention Rate of 126% increased sequentially and from the prior year quarter demonstrating the strength in cross selling and upselling to clients most notably due to the new ATP rights deal and market growth in the United States.

Profit for the period from continuing operations

Profit for the period from continuing operations in the third quarter was €37 million, up €32 million, compared to €5 million in the same quarter a year ago. The increase was primarily driven by the strong operating results as well as €21 million in net foreign currency gains due to strengthening of the Euro against the U.S. dollar and €15 million of prior year one-time losses related to impairment on goodwill and intangible assets related to the impact of changes related to our business strategy and disposal of an equity-accounted investee. These increases were partially offset by higher financing costs of €14 million driven by the new ATP, NBA, and Bundesliga partnership deals.

Adjusted EBITDA

Third quarter Adjusted EBITDA was €66 million, up €15 million, compared to €50 million in the same quarter a year ago. The increase was primarily driven by the 27% revenue growth, partially offset by increased sport rights costs primarily related to the ATP partnership deal, higher purchased services driven by investments in developing our product portfolio, increased personnel expenses due to headcount growth and a higher bonus accrual in the current year.

Additional Business Highlights

  • In conjunction with our partnership with the NBA, Sportradar has launched a suite of next generation products and solutions for the 2024 – 2025 season. Leveraging products such as 4Sight Streaming, emBET, Live Match Tracker and advanced visualizations, Sportradar can harness hundreds of thousands of data points per game to redefine the standards of fan engagement.
  • Sportradar introduced micro markets for ATP tennis matches in collaboration with Tennis Data Innovations, expanding this cutting-edge product to tennis from other popular sports such as soccer and table tennis. The eight distinct micro markets are expected to generate approximately 1,500 new betting opportunities per match, opening fresh revenue streams for operators.
  • Sportradar added paid search to its ad:s marketing service, allowing operators to more effectively reach and acquire customers searching betting and gaming-related topics online.
  • Sportradar received several industry awards, including the Best Live Betting Product at SBC Summit 2024. In addition, Sportradar was recognized in two prestigious categories at the 2024 American Gambling Awards, winning Betting Product of the Year for its 4Sight technology and the Data Service Provider of the Year.

Balance Sheet and Liquidity

The Company’s cash and cash equivalents were €368 million as of September 30, 2024 as compared with €277 million as of December 31, 2023. The increase was primarily driven by net cash generated from operating activities of €271 million due to the strong operating performance, partially offset by net cash used in investing activities of €152 million, primarily from the acquisition of additional sports rights, most notably our new NBA and ATP deals, and from net cash used in financing activities of €26 million, due primarily to share repurchases. Free cash flow for the nine-months ended September 30, 2024 was €122 million, an increase of €71 million from the €51 million in the same period a year ago.

Including the undrawn credit facility, the Company had total liquidity of €588 million at September 30, 2024 as compared to €510 million as of September 30, 2023, and no debt outstanding.

2024 Annual Financial Outlook

Sportradar is further raising its fiscal 2024 outlook for revenue and Adjusted EBITDA as follows:

  • Revenue of at least €1,090 million, up 24% year-over-year, compared with prior outlook of €1,070 million.
  • Adjusted EBITDA of at least €216 million, up 29% year-over-year, compared with prior outlook of €204 million.
  • Adjusted EBITDA margin of approximately 20%.

Share Repurchase Program

In March of this year the Board of Directors approved a $200 million share repurchase program and commenced purchases during the second quarter. During the current quarter, the Company repurchased approximately 721,000 shares for a total of $8.3 million. Year to date through November 1, 2024, the Company has repurchased 1.7 million shares under the plan for a total of approximately $20 million.

Conference Call and Webcast Information

Sportradar will host a conference call to discuss the third quarter 2024 results today, November 7, 2024, at 8:00 a.m. Eastern Time. Those wishing to participate via webcast should access the earnings call through Sportradar’s Investor Relations website. An archived webcast with the accompanying slides will be available at the Company’s Investor Relations website for one year after the conclusion of the live event.

About Sportradar

Sportradar Group AG SRAD, founded in 2001, is a leading global sports technology company creating immersive experiences for sports fans and bettors. Positioned at the intersection of the sports, media and betting industries, the Company provides sports federations, news media, consumer platforms and sports betting operators with a best-in-class range of solutions to help grow their business. As the trusted partner of organizations like the ATP, NBA, NHL, MLB, NASCAR, UEFA, FIFA, and Bundesliga, Sportradar covers close to a million events annually across all major sports. With deep industry relationships and expertise, Sportradar is not just redefining the sports fan experience, it also safeguards sports through its Integrity Services division and advocacy for an integrity-driven environment for all involved.

For more information about Sportradar, please visit www.sportradar.com

_______________________________________________________________________

Non-IFRS measure. See the sections captioned “Non-IFRS Financial Measures and Operating Metric” and “IFRS to Non-IFRS reconciliations” for more details.

CONTACT:

Investor Relations:
Jim Bombassei
j.bombassei@sportradar.com

Media:
Sandra Lee
press@sportradar.com

Non-IFRS Financial Measures and Operating Metric

We have provided in this press release financial information that has not been prepared in accordance with IFRS, including Adjusted EBITDA, Adjusted EBITDA margin, Adjusted purchased services, Adjusted personnel expenses, Adjusted other operating expenses, and Free cash flow, as well as our operating metric, Customer Net Retention Rate. We use these non-IFRS financial measures internally in analyzing our financial results and believe they are useful to investors, as a supplement to IFRS measures, in evaluating our ongoing operational performance. We believe that the use of these non-IFRS financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial results with other companies in our industry, many of which present similar non-IFRS financial measures to investors.

Non-IFRS financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with IFRS. Investors are encouraged to review the reconciliation of these non-IFRS financial measures to their most directly comparable IFRS financial measures provided in the financial statement tables included below in this press release.

  • “Adjusted EBITDA” represents earnings for the period from continuing operations adjusted for finance income and finance costs, income tax expense or benefit, depreciation and amortization (excluding amortization of capitalized sport rights licenses), foreign currency gains or losses, and other items that are non-recurring or not related to the Company’s revenue-generating operations, including share-based compensation, impairment charges or income, management restructuring costs, non-routine litigation costs, losses related to equity-accounted investee (SportTech AG), and professional fees for the Sarbanes-Oxley Act of 2002 and enterprise resource planning implementations.
    License fees relating to sport rights are a key component of how we generate revenue and one of our main operating expenses. Only licenses that meet the recognition criteria of IAS 38 are capitalized. The primary distinction for whether a license is capitalized or not capitalized is the contracted length of the applicable license. Therefore, the type of license we enter into can have a significant impact on our results of operations depending on whether we are able to capitalize the relevant license. As such, our presentation of Adjusted EBITDA reflects the full costs of our sport right’s licenses. Management believes that, by including amortization of sport rights in its calculation of Adjusted EBITDA, the result is a financial metric that is both more meaningful and comparable for management and our investors while also being more indicative of our ongoing operating performance.
    We present Adjusted EBITDA because management believes that some items excluded are non-recurring in nature and this information is relevant in evaluating the results relative to other entities that operate in the same industry. Management believes Adjusted EBITDA is useful to investors for evaluating Sportradar’s operating performance against competitors, which commonly disclose similar performance measures. However, Sportradar’s calculation of Adjusted EBITDA may not be comparable to other similarly titled performance measures of other companies. Adjusted EBITDA is not intended to be a substitute for any IFRS financial measure.
    Items excluded from Adjusted EBITDA include significant components in understanding and assessing financial performance. Adjusted EBITDA has limitations as an analytical tool and should not be considered in isolation, or as an alternative to, or a substitute for, profit for the period, revenue or other financial statement data presented in our consolidated financial statements as indicators of financial performance. We compensate for these limitations by relying primarily on our IFRS results and using Adjusted EBITDA only as a supplemental measure.
  • “Adjusted EBITDA margin” is the ratio of Adjusted EBITDA to revenue.
    The Company is unable to provide a reconciliation of Adjusted EBITDA guidance to profit (loss) for the period, its most directly comparable IFRS financial measure, on a forward-looking basis without unreasonable effort because items that impact this IFRS financial measure are not within the Company’s control and/or cannot be reasonably predicted. These items may include but are not limited to foreign exchange gains and losses. Such information may have a significant, and potentially unpredictable, impact on the Company’s future financial results.

We present Adjusted purchased services, Adjusted personnel expenses, and Adjusted other operating expenses (“Non-IFRS expenses”) because management utilizes these financial measures to manage its business on a day-to-day basis and believes that they are the most relevant measures of expenses. Management believes these adjusted expense measures provide expanded insight to assess revenue and cost performance, in addition to the standard IFRS-based financial measures. Management believes these adjusted expense measures are useful to investors for evaluating Sportradar’s operating performance against competitors. However, Sportradar’s calculation of adjusted expense measures may not be comparable to other similarly titled performance measures of other companies. These adjusted expense measures are not intended to be a substitute for any IFRS financial measure.

  • Adjusted purchased services” represents purchased services less capitalized external development costs.
  • Adjusted personnel expenses” represents personnel expenses less share-based compensation awarded to employees, management restructuring costs, and capitalized personnel compensation.
  • Adjusted other operating expenses” represents other operating expenses plus impairment loss on trade receivables, less non-routine litigation, share-based compensation awarded to third parties, and certain professional fees.

We consider Free cash flow to be a liquidity measure that provides useful information to management and investors about the amount of cash generated by the business after the purchase of property and equipment, the purchase of intangible assets and payment of lease liabilities, which can then be used, among other things, to invest in our business and make strategic acquisitions. A limitation of the utility of Free cash flow as a measure of liquidity is that it does not represent the total increase or decrease in our cash balance for the year.

  • Free cash flow” represents net cash from operating activities adjusted for payments for lease liabilities, acquisition of property and equipment, and acquisition of intangible assets.

In addition, we define the following operating metric as follows:

  • “Customer Net Retention Rate” is calculated for a given period by starting with the reported Trailing Twelve Month revenue from our top 200 customers as of twelve months prior to such period end, or prior period revenue. We then calculate the reported trailing twelve-month revenue from the same customer cohort as of the current period end, or current period revenue. Current period revenue includes any upsells and is net of contraction and attrition over the trailing twelve months but excludes revenue from new customers in the current period. We then divide the total current period revenue by the total prior period revenue to arrive at our Net Retention Rate.

Safe Harbor for Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking” statements and information within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events, including, without limitation, statements regarding future financial or operating performance, planned activities and objectives, anticipated growth resulting therefrom, market opportunities, strategies and other expectations, and our guidance and outlook, including expected performance for the full year 2024. In some cases, these forward-looking statements can be identified by words or phrases such as “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “seek,” “believe,” “estimate,” “predict,” “potential,” “projects”, “continue,” “contemplate,” “confident,” “possible” or similar words. These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation, the following: economy downturns and political and market conditions beyond our control, including the impact of the Russia/Ukraine and other military conflicts and foreign exchange rate fluctuations; pandemics, such as the global COVID-19 pandemic, could have an adverse effect on our business; dependence on our strategic relationships with our sports league partners; effect of social responsibility concerns and public opinion on responsible gaming requirements on our reputation; potential adverse changes in public and consumer tastes and preferences and industry trends; potential changes in competitive landscape, including new market entrants or disintermediation; potential inability to anticipate and adopt new technology; potential errors, failures or bugs in our products; inability to protect our systems and data from continually evolving cybersecurity risks, security breaches or other technological risks; potential interruptions and failures in our systems or infrastructure; our ability to comply with governmental laws, rules, regulations, and other legal obligations, related to data privacy, protection and security; ability to comply with the variety of unsettled and developing U.S. and foreign laws on sports betting; dependence on jurisdictions with uncertain regulatory frameworks for our revenue; changes in the legal and regulatory status of real money gambling and betting legislation on us and our customers; our inability to maintain or obtain regulatory compliance in the jurisdictions in which we conduct our business; our ability to obtain, maintain, protect, enforce and defend our intellectual property rights; our ability to obtain and maintain sufficient data rights from major sports leagues, including exclusive rights; any material weaknesses identified in our internal control over financial reporting; inability to secure additional financing in a timely manner, or at all, to meet our long-term future capital needs; risks related to future acquisitions; and other risk factors set forth in the section titled “Risk Factors” in our Annual Report on Form 20-F for the fiscal year ended December 31, 2023, and other documents filed with or furnished to the SEC, accessible on the SEC’s website at www.sec.gov and on our website at https://investors.sportradar.com. These statements reflect management’s current expectations regarding future events and operating performance and speak only as of the date of this press release. One should not put undue reliance on any forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.


SPORTRADAR GROUP AG

CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
(Unaudited)

    Three-Month Period Ended   Nine-Month Period Ended
    September 30, 2024   September 30, 2023   September 30, 2024   September 30, 2023
in €’000 and in thousands of shares       (restated)       (restated)
Continuing operations                
Revenue   255,172     201,037     799,486     625,035  
Personnel expenses   (87,966 )   (75,359 )   (256,668 )   (237,223 )
Sport rights expenses (including amortization of capitalized sport rights licenses)   (63,002 )   (35,544 )   (249,861 )   (139,077 )
Purchased services   (42,770 )   (36,088 )   (125,565 )   (103,650 )
Other operating expenses   (23,391 )   (22,817 )   (67,388 )   (65,000 )
Impairment gain (loss) on trade receivables, contract assets and other financial assets   397     (626 )   (3,473 )   (4,527 )
Internally-developed software cost capitalized   13,269     8,415     36,186     19,665  
Depreciation and amortization (excluding amortization of capitalized sport rights licenses)   (12,970 )   (11,812 )   (37,600 )   (33,465 )
Share of loss of equity-accounted investee               (3,699 )
Loss on disposal of equity-accounted investee       (5,600 )       (13,618 )
Impairment loss on goodwill and intangible assets       (9,854 )       (9,854 )
Foreign currency gain (loss), net   22,380     1,187     88     (3,714 )
Finance income   2,738     3,179     6,687     9,781  
Finance costs   (19,969 )   (5,554 )   (57,986 )   (17,672 )
Net income before tax from continuing operations   43,888     10,564     43,906     22,982  
Income tax expense   (6,786 )   (5,949 )   (8,988 )   (11,524 )
Profit for the period from continuing operations   37,102     4,615     34,918     11,458  
Discontinued operations                
Loss from discontinued operations       (495 )       (451 )
Profit for the period   37,102     4,120     34,918     11,007  
                 
Other comprehensive income                
Items that will not be reclassified subsequently to profit or (loss)                
Remeasurement of defined benefit liability       1     (2 )   (88 )
Related deferred tax expense (benefit)           (2 )   11  
        1     (4 )   (77 )
Items that may be reclassified subsequently to profit or (loss)                
Foreign currency translation adjustment attributable to the owners of the company   (4,163 )   3,420     2,321     3,062  
Foreign currency translation adjustment attributable to non-controlling interests   (3 )   (25 )   (5 )   (17 )
    (4,166 )   3,395     2,316     3,045  
Other comprehensive (loss) income for the period, net of tax   (4,166 )   3,396     2,312     2,968  
Total comprehensive income for the period   32,936     7,516     37,230     13,975  
                 
Profit (loss) attributable to:                
Owners of the Company   37,261     4,335     35,239     11,246  
Non-controlling interests   (159 )   (215 )   (321 )   (239 )
    37,102     4,120     34,918     11,007  
Total comprehensive income (loss) attributable to:                
Owners of the Company   33,098     7,756     37,556     14,230  
Non-controlling interests   (162 )   (240 )   (326 )   (255 )
    32,936     7,516     37,230     13,975  
                 
                 
Profit per Class A share attributable to owners of the Company                
Basic   0.12     0.02     0.12     0.04  
Diluted   0.11     0.01     0.11     0.04  
Profit per Class B share attributable to owners of the Company                
Basic   0.01     0.00     0.01     0.00  
Diluted   0.01     0.00     0.01     0.00  
                 
Weighted-average number of shares                
Weighted-average number of Class A shares (basic)   210,467     207,600     210,202     207,283  
Weighted-average number of Class A shares (diluted)   227,805     220,834     226,284     219,676  
Weighted-average number of Class B shares (basic and diluted)   903,671     903,671     903,671     903,671  
                         


SPORTRADAR GROUP AG

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(Unaudited)

in €’000   September 30,
2024
  December 31,
2023
Assets        
Current assets        
Cash and cash equivalents   368,379     277,174  
Trade receivables   66,240     71,246  
Contract assets   94,950     60,869  
Other assets and prepayments   27,189     33,252  
Income tax receivables   6,470     6,527  
Total current assets   563,228     449,068  
Non-current assets        
Property and equipment   66,273     72,762  
Intangible assets and goodwill   1,618,722     1,697,331  
Other financial assets and other non-current assets   11,491     11,806  
Deferred tax assets   17,566     16,383  
Total non-current assets   1,714,052     1,798,282  
Total assets   2,277,280     2,247,350  
Liabilities and equity        
Current liabilities        
Loans and borrowings   10,050     9,586  
Trade payables   246,887     259,667  
Other liabilities   60,703     55,724  
Contract liabilities   42,594     26,595  
Income tax liabilities   8,978     4,542  
Total current liabilities   369,212     356,114  
Non-current liabilities        
Loans and borrowings   37,174     40,559  
Trade payables   892,966     908,499  
Contract liabilities   41,196     39,526  
Other non-current liabilities   1,419     8,500  
Deferred tax liabilities   19,081     21,315  
Total non-current liabilities   991,836     1,018,399  
Total liabilities   1,361,048     1,374,513  
Equity        
Ordinary shares   27,551     27,421  
Treasury shares   (18,144 )   (2,322 )
Additional paid-in capital   669,795     653,840  
Retained earnings   214,771     173,629  
Other reserves   17,542     15,226  
Equity attributable to owners of the Company   911,515     867,794  
Non-controlling interest   4,717     5,043  
Total equity   916,232     872,837  
Total liabilities and equity   2,277,280     2,247,350  
             


SPORTRADAR GROUP AG

CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

    Nine-Month Period Ended
    September 30, 2024   September 30, 2023
in €’000       (restated)
OPERATING ACTIVITIES:        
Profit for the period   34,918     11,007  
Adjustments to reconcile profit for the period to net cash provided by operating activities:        
Income tax expense   8,988     11,524  
Interest income   (6,818 )   (5,573 )
Interest expense   58,081     15,861  
Foreign currency (gain) loss, net   (88 )   3,714  
Depreciation and amortization (excluding amortization of capitalized sport rights licenses)   37,600     33,465  
Amortization of capitalized sport rights licenses   166,603     97,330  
Impairment losses on goodwill and intangible assets       9,854  
Equity-settled share-based payments   26,052     31,107  
Share of loss of equity-accounted investee       3,699  
Loss on disposal of equity-accounted investee       13,618  
Other   (8,048 )   389  
Cash flow from operating activities before working capital changes, interest and income taxes   317,288     225,995  
Increase in trade receivables, contract assets, other assets and prepayments   (24,555 )   (1,212 )
Increase in trade and other payables, contract and other liabilities   36,095     324  
Changes in working capital   11,540     (888 )
Interest paid   (57,287 )   (15,009 )
Interest received   6,823     5,566  
Income taxes paid, net   (7,510 )   (9,216 )
Net cash from operating activities   270,854     206,448  
INVESTING ACTIVITIES:        
Acquisition of intangible assets   (140,165 )   (145,085 )
Acquisition of property and equipment   (3,090 )   (5,638 )
Acquisition of subsidiaries, net of cash acquired   (8,240 )   (12,286 )
Acquisition of financial assets       (3,716 )
Proceeds from disposal of equity-accounted investee       15,172  
Change in loans receivable and deposits   (187 )   (952 )
Net cash used in investing activities   (151,682 )   (152,505 )
FINANCING ACTIVITIES:        
Payment of lease liabilities   (5,898 )   (4,933 )
Purchase of treasury shares   (19,795 )   (7,101 )
Principal payments on bank debt   (150 )   (510 )
Change in bank overdrafts   (47 )   17  
Net cash used in financing activities   (25,890 )   (12,527 )
Net increase in cash   93,282     41,416  
Cash and cash equivalents at beginning of period   277,174     243,757  
Effects of movements in exchange rates   (2,077 )   4,528  
Cash and cash equivalents at end of period   368,379     289,701  
             


Change in presentation related to sport rights expenses

During the third quarter, the Company has changed the presentation of expenses related to sport rights in its Statement of profit or loss and other comprehensive income. Previously, these expenses were split between ‘Purchased services and licenses (excluding depreciation and amortization)’, representing the portion of related sport rights expenses which were not eligible for capitalization and ‘Depreciation and amortization’, representing the portion of related sport rights expenses which were capitalized. However, starting this quarter, the expenses are combined and presented under a new line item titled ‘Sport rights expenses (including amortization of capitalized licenses)’.

The change in presentation intends to provide more relevant and reliable information to the users of our financial statements. This reclassification aligns the presentation of sport rights expenses with the nature of the costs and the way they are managed internally.

There is no change to the Company’s disclosures, measurement or recognition of non-capitalized costs and capitalized sport rights licenses in accordance with IAS 38 Intangible Assets reported in its Annual Report on Form 20-F for the year ended December 31, 2023.

The following table shows the reclassification of sport rights expenses (unaudited):

         
    Three-Month Period Ended
September 30, 2023
  Nine-Month Period Ended
September 30, 2023
in €’000   Previously reported   Reclassification1   Restated   Previously reported   Reclassification1   Restated
Purchased services and licenses (excluding depreciation and amortization)   (45,260 )   9,172   (36,088 )   (138,245 )   34,595   (103,650 )
Depreciation and amortization   (38,184 )   26,372   (11,812 )   (137,947 )   104,482   (33,465 )
Total sport rights expenses       35,544           139,077    
                         

1 Approximately €1.2 million and €7.2 million of sport rights expenses has been reclassified from amortization to purchased services and licenses for the three-month and nine-month periods ended September 30, 2023 as previously reported in the Company’s Form 6-K dated November 1, 2023.

Additional disclosures related to sport rights expenses

The following table shows the composition of sport rights expenses (unaudited):

         
    Three-Month Period Ended   Nine-Month Period Ended
in €’000   September 30, 2024   September 30, 2023   September 30, 2024   September 30, 2023
Non-capitalized sport right expenses   28,272   10,354   83,258   41,747
Amortization of capitalized sport rights   34,730   25,190   166,603   97,330
Total sport rights expenses   63,002   35,544   249,861   139,077
                 

IFRS to Non-IFRS Reconciliations

The following table reconciles Adjusted EBITDA to the most directly comparable IFRS financial performance measure, which is Profit for the period from continuing operations (unaudited):

         
    Three-Month Period Ended   Nine-Month Period Ended
in €’000   September 30, 2024   September 30, 2023   September 30, 2024   September 30, 2023
Profit for the period from continuing operations   37,102     4,615     34,918     11,458  
Finance income   (2,738 )   (3,179 )   (6,687 )   (9,781 )
Finance costs   19,969     5,554     57,986     17,672  
Depreciation and amortization (excluding amortization of capitalized sport rights licenses)   12,970     11,812     37,600     33,465  
Foreign currency (gain) loss, net   (22,380 )   (1,187 )   (88 )   3,714  
Share-based compensation   12,088     11,368     25,095     31,430  
Management restructuring costs           1,620      
Non-routine litigation costs   1,989         2,391      
Share of loss of equity-accounted investee               3,699  
Loss on disposal of equity-accounted investee       5,600         13,618  
Impairment loss on goodwill and intangible assets       9,854         9,854  
Impairment loss on other financial assets               202  
Professional fees for SOX and ERP implementations       100         404  
Income tax expense   6,786     5,949     8,988     11,524  
Adjusted EBITDA   65,786     50,486     161,823     127,259  
                         

The most directly comparable IFRS measure of Adjusted EBITDA margin is Profit for the period from continuing operations as a percentage of revenue as disclosed below (unaudited):

         
    Three-Month Period Ended   Nine-Month Period Ended
in €’000   September 30, 2024   September 30, 2023   September 30, 2024   September 30, 2023
Profit for the period from continuing operations   37,102     4,615     34,918     11,458  
Revenue   255,172     201,037     799,486     625,035  
Profit for the period from continuing operations as a percentage of revenue   14.5 %   2.3 %   4.4 %   1.8 %
                         

The most directly comparable IFRS measure of Free cash flow is Net cash from operating activities as disclosed below (unaudited):

         
    Three-Month Period Ended   Nine-Month Period Ended
in €’000   September 30, 2024   September 30, 2023   September 30, 2024   September 30, 2023
Net cash from operating activities   118,222     76,248     270,854     206,448  
Acquisition of intangible assets   (53,552 )   (50,878 )   (140,165 )   (145,085 )
Acquisition of property plant and equipment   (717 )   (2,392 )   (3,090 )   (5,638 )
Payment of lease liabilities   (1,741 )   (1,650 )   (5,898 )   (4,933 )
Free cash flow   62,212     21,328     121,701     50,792  
                         

The following tables show reconciliations of IFRS expenses included in profit for the period from continuing operations to expenses included in Adjusted EBITDA (unaudited):

         
    Three-Month Period Ended   Nine-Month Period Ended
in €’000   September 30, 2024   September 30, 2023   September 30, 2024   September 30, 2023
Purchased services   42,770     36,088     125,565     103,650  
Less: capitalized external services   (6,490 )   (1,669 )   (15,758 )   (4,242 )
Adjusted purchased services   36,280     34,419     109,807     99,408  
                 
Personnel expenses   87,966     75,359     256,668     237,223  
Less: share-based compensation   (12,767 )   (11,107 )   (27,076 )   (30,661 )
Less: management restructuring           (1,620 )    
Less: capitalized personnel compensation   (5,865 )   (6,746 )   (17,741 )   (15,423 )
Adjusted personnel expenses   69,334     57,506     210,231     191,139  
                 
Other operating expenses   23,391     22,817     67,388     65,000  
Less: non-routine litigation   (1,989 )       (2,391 )    
Less: share-based compensation   (237 )   (261 )   (706 )   (769 )
Less: other       (100 )       (606 )
Add: impairment (gain) loss on trade receivables   (397 )   626     3,473     4,527  
Adjusted other operating expenses   20,768     23,082     67,764     68,152  


Primary Logo

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.